ONXX Onyx Pharmaceuticals, Inc. (MM)

EMERYVILLE, Calif., June 2 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will present at the Goldman Sachs 30th Annual Global Healthcare Conference on Tuesday, June 9, at 10:10 a.m. Eastern Time. Interested parties may access a live webcast of the presentation on our website at: http://www.onyx-pharm.com/wt/page/event_calendar It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. For those unable to participate during the live webcast, a recorded replay of the presentation will be available one hour following the conclusion of the presentation through July 9, 2009. Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(R), a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. For more information about Onyx, visit the company's website at http://www.onyx-pharm.com/. Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer Pharmaceuticals Corporation. DATASOURCE: Onyx Pharmaceuticals, Inc. CONTACT: Alex Santos, +1-510-597-6504, for Onyx Pharmaceuticals, Inc. Web Site: http://www.onyx-pharm.com/

Copyright